Scarica l'app Stockscreener
0.3599
6.68%
0.0349
Precedente Chiudi:
$0.325
Aprire:
$0.33
Volume 24 ore:
171.90K
Relative Volume:
0.01
Capitalizzazione di mercato:
$21.19M
Reddito:
$7.11M
Utile/perdita netta:
$-41.28M
Rapporto P/E:
-0.2608
EPS:
-1.38
Flusso di cassa netto:
$-26.84M
1 W Prestazione:
+1.29%
1M Prestazione:
-1.14%
6M Prestazione:
+49.70%
1 anno Prestazione:
-62.72%
Intervallo 1D:
$0.328
$0.348
Intervallo di 1 settimana:
$0.3201
$0.3617
Portata 52W:
$0.2275
$1.55
Co Diagnostics Inc Stock (CODX) Company Profile
Nome
Co Diagnostics Inc
Settore
Industria
Telefono
(801) 278-9769
Indirizzo
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Confronta CODX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.348 | 19.79M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
128.38 | 222.66B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
101.20 | 150.26B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
372.77 | 143.44B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
105.92 | 135.12B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.97 | 50.38B | 5.88B | 1.34B | 799.60M | 2.3489 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-12 | Downgrade | Sidoti | Buy → Neutral |
| 2021-12-29 | Iniziato | Sidoti | Buy |
| 2021-03-29 | Downgrade | Maxim Group | Buy → Hold |
| 2020-05-20 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-05-18 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-03 | Downgrade | Maxim Group | Buy → Hold |
Mostra tutto
Co Diagnostics Inc Borsa (CODX) Ultime notizie
HC Wainwright & Co. Reiterates Co-Diagnostics (CODX) Neutral Recommendation - Nasdaq
HC Wainwright Reiterates Neutral Rating for Co-Diagnostics (CODX) | CODX Stock News - GuruFocus
Can Co Diagnostics Inc. stock hit analyst price targets2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Will Co Diagnostics Inc. stock attract ESG investorsEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - newser.com
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health - The Herald Journal
Co-Diagnostics (NASDAQ: CODX) Details Co-Dx PCR MTB Test Plans for 30,000 India Clinics - Stock Titan
Developing predictive dashboards with Co Diagnostics Inc. dataDollar Strength & Fast Moving Stock Trade Plans - newser.com
Chart overlay techniques for tracking Co Diagnostics Inc.Earnings Recap Report & Daily Profit Maximizing Tips - newser.com
Co-Diagnostics (CODX) Q3 2025 Earnings Transcript - AOL.com
Predicting Co Diagnostics Inc. trend using moving averagesWeekly Loss Report & Safe Capital Growth Tips - newser.com
Why Co Diagnostics Inc. stock remains on buy listsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com
MSN Money - MSN
What technical models suggest about Co Diagnostics Inc.’s comebackTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Will Co Diagnostics Inc. stock benefit from AI adoptionWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
How sentiment analysis helps forecast Co Diagnostics Inc.2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN
How Co Diagnostics Inc. stock trades during market volatilityWeekly Market Outlook & AI Powered Trade Plan Recommendations - newser.com
Co-Diagnostics Inc. (CODX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dxtm PCR Platform to Support Submission to the U.S. FDA - Lelezard
Co-Diagnostics Initiates Clinical Evaluations for Upper Respirat - GuruFocus
Co-Diagnostics initiates clinical evaluations for upper respiratory multiplex point-of-care test on Co-Dx(TM) PCR platform to support submission to the U.S. FDA - MarketScreener
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA - WV News
Sentiment analysis tools applied to Co Diagnostics Inc.July 2025 Volume & Community Consensus Picks - newser.com
What recovery options are there for Co Diagnostics Inc.July 2025 Fed Impact & Accurate Buy Signal Notifications - newser.com
Is Co Diagnostics Inc. stock a top momentum playJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Is Co Diagnostics Inc. stock attractive after correctionEarnings Beat & Daily Market Momentum Tracking - newser.com
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates - MSN
Will Co Diagnostics Inc. stock remain a Wall Street favoriteJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Is Co Diagnostics Inc. stock positioned well for digital economyDay Trade & Verified High Yield Trade Plans - Fundação Cultural do Pará
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2025 Earnings Call Transcript - Insider Monkey
What margin trends mean for Co Diagnostics Inc. stockJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - Fundação Cultural do Pará
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ... By GuruFocus - Investing.com Canada
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ... - Yahoo Finance
Co-Diagnostics Expands Global Reach and Innovates with AI - TipRanks
Co Diagnostics Inc Azioni (CODX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):